Alboni P, Malacarne C, Tomasi A M, Masoni A
G Ital Cardiol. 1977;7(9):862-9.
The electrophysiologic effects of tolamolol (UK-6558-01), a new beta-adrenergic blocking agent, were studied using the endocavitarian electrocardiography and the extrastimulus method. The drug was infused intravenously in the dose of 20 mg (0,23-0,36 mg per kilogram). Tolamolol resulted in: -- prolongation of sinus cycle length in 17 patients (P less than 0.001); -- prolongation of correct sinus node recovery time in 16 patients (P less than 0.001); -- there was no significant modification in intra-atrial conduction (P less than 0.3), while atrail effective refractory period was slightly lengthened (P less than 0.03); -- in A-V node conduction was prolonged in 17 patients (P less than 0.001) and the effective functional refractory periods were prolonged in all patients (P less than 0.001); -- a A-V block of 2 degrees grade appears in 17 patients at a more prolonged cycle length (P less than 0.001). Tolamolol had no effect on His-Purkinje system conduction time as well as the relative refractory period, measured before and after the drug in 2 patients. In 6 patients, during the induction of extrastimuli an "echo zone" appeared; after tolamolol its duration was reduced in 4 patients, in one unchanged and in one abolished. The therapeutical properties of this drug are discussed on the basis of such experimental data.
使用心腔内心电图和额外刺激法研究了新型β肾上腺素能阻滞剂托拉洛尔(UK - 6558 - 01)的电生理效应。以20毫克(每公斤0.23 - 0.36毫克)的剂量静脉输注该药物。托拉洛尔导致:——17例患者窦性周期长度延长(P < 0.001);——16例患者窦房结恢复时间延长(P < 0.001);——心房内传导无显著改变(P < 0.3),而心房有效不应期略有延长(P < 0.03);——17例患者房室结传导延长(P < 0.001),所有患者有效功能不应期延长(P < 0.001);——17例患者在更长的周期长度时出现二度房室传导阻滞(P < 0.001)。托拉洛尔对2例患者用药前后测量的希氏 - 浦肯野系统传导时间以及相对不应期无影响。6例患者在诱发额外刺激时出现“回声区”;使用托拉洛尔后,4例患者其持续时间缩短,1例不变,1例消失。基于这些实验数据讨论了该药物的治疗特性。